Filing Flows › Camp4 Therapeutics (CAMP) › Q1 2025
Camp4 Therapeutics (CAMP) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 13, 2025
Camp4 Therapeutics (CAMP) reported revenue of $858K for the first quarter 2025 (Q1 2025) and +32% from the quarter before.
Camp4 Therapeutics, Q1 2025: revenue $858K, net loss $12.4M, operating cash flow −$14.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $858K | +32% | — |
| Operating profit | −$13.1M | — | — |
| Net earnings | −$12.4M | — | — |
| Operating cash flow | −$14.3M | — | — |
What changed
Revenue was $858K in Q1 2025, up 32% from the previous quarter.
Operating costs exceeded revenue by $13.1M, an operating margin of -1526.8%. The quarter ended with a net loss of $12.4M, narrower than the previous quarter's $13.3M loss.
Operating cash flow was −$14.3M. Non-cash charges added back $421K of depreciation and amortization and $861K of share-based compensation. Working capital and other items used $3.1M. Capital expenditures of $279K exceeded it, leaving free cash flow of −$14.6M.
Questions
What was Camp4 Therapeutics' revenue in the first quarter 2025?
Camp4 Therapeutics (CAMP) reported revenue of $858K for the first quarter 2025 (Q1 2025) and +32% from the quarter before.
Source: Camp4 Therapeutics 10-Q on SEC EDGAR.